Insider · CIK 0001215126
Margaret G McGlynn
Files at NVAX (NOVAVAX INC), FOLD (AMICUS THERAPEUTICS, INC.). First filing -, latest -.
Margaret G McGlynn files SEC Form 4 as director at NVAX (NOVAVAX INC), and also at FOLD (AMICUS THERAPEUTICS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Margaret G McGlynn has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Common Stock | -94,631 | $14.50 | $1.4M | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -20,000 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -16,236 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -19,473 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -18,574 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -36,111 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -45,423 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -30,474 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -42,467 | - | - | 0 | Apr 27, 2026 |
| Apr 27, 2026 | FOLD AMICUS THERAPEUTICS, INC. | DDisposition to issuer Stock Options (right to buy)derivative | -74,872 | - | - | 0 | Apr 27, 2026 |
| Jun 20, 2025 | NVAX NOVAVAX INC | AGrant or award Stock Option (Right to Buy)derivative | +28,326 | $6.42 | $182k | 28,326 | Jun 24, 2025 |
| Jun 20, 2025 | NVAX NOVAVAX INC | AGrant or award Restricted Stock Unitsderivative | +18,884 | $0.00 | $0 | 18,884 | Jun 24, 2025 |
| Jun 12, 2025 | NVAX NOVAVAX INC | MOption exercise Common Stock | +10,420 | $0.00 | $0 | 25,588 | Jun 16, 2025 |
| Jun 12, 2025 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -10,420 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 5, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Common Stock | +20,414 | $0.00 | $0 | 91,550 | Jun 6, 2025 |
| Jun 5, 2025 | FOLD AMICUS THERAPEUTICS, INC. | AGrant or award Stock Options (right to buy)derivative | +74,872 | $0.00 | $0 | 74,872 | Jun 6, 2025 |
Questions about Margaret G McGlynn
Answered from the filings on this page, as of the latest one.
Is Margaret G McGlynn buying or selling?
Margaret G McGlynn has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Margaret G McGlynn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Margaret G McGlynn has 0.
Where does Margaret G McGlynn file Form 4?
Margaret G McGlynn has filed Form 4 at NVAX (NOVAVAX INC); FOLD (AMICUS THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.